Skip to main navigation Skip to search Skip to main content

C19: The efficacy of a novel technology to prevent the transmissibility, viability, and infectivity by neutralizing SARS-COV-2 virus in the air and surfaces

Project: Research

Project Details

StatusFinished
Effective start/end date11/15/2005/15/21

Funding

  • Shreis Scalene Therapeutics: $17,199.00